Thrombosis
Advertisement
VRd was associated with lower rates of venous thromboembolism versus KRd in patients with newly-diagnosed multiple myeloma.
Intracardiac thrombosis in patients with COVID-19 was associated with increased all-cause and cardiovascular mortality.
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk.
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Results from the OCEAN-TAVI registry indicate that a non-antithrombotic strategy may be reasonable following ...
In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ...
In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ...
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ...
DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ...
According to a recent study, the use of short-term, low-dose dabigatran could significantly reduce the risk of bleeding ...
The clinical impact of subclinical leaflet thrombosis following transcatheter aortic valve replacement (TAVR) is ...
Researchers assessed the UK experience of kidney transplantations from deceased donors who had vaccine-induced immune ...
Researchers reported that "assessing total arterial and venous thrombotic events, not just first events, provides more ...
In a study in Research and Practice in Thrombosis and Haemostasis, researchers examined changes in clinical and platelet ...
Researchers explored the optimal duration of triple antithrombotic therapy (TAT) in patients who have atrial ...
Therapies that can reduce risk of thrombosis without increasing bleeding complications are needed to improve stroke ...
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.